ContextVision AB presents Q3 2015 report
22 October, 2015 Strong third quarter for ContextVision ContextVision AB (OSE: COV), the medical imaging software company, today announced its third quarter 2015 financial results. ContextVision achieved one of its best quarterly financial results ever, despite expanded R&D activity. ContextVision's cash position was the strongest in Company history at the end of the quarter, enabling the Company to pursue its ambitious R&D strategy. Sales in the third quarter increased by more than 15 per cent compared to last year and ended at SEK 17.0 million, up from SEK 14.8 million. The